查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405779

液體活體組織切片市場規模、佔有率、趨勢分析報告：按生物標記、按應用、按技術、按樣本類型、按臨床應用、按最終用途、按產品、按地區、細分市場預測，2024-2030 年

Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker, By Application, By Technology, By Sample Type, By Clinical Application, By End-use, By Product, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

液體活體組織切片市場成長和趨勢：

2030年，全球液體切片市場規模為228.8億美元，預計2023年至2030年複合年成長率為9.7%。

癌症盛行率的增加和老年人口的增加是預計推動市場成長的主要因素。此外，使用技術先進的設備進行疾病的早期檢測是推動市場的關鍵因素之一。此外，對非侵入性治療程序的日益偏好可能會在預測期內提供利潤豐厚的機會。

近年來，受癌症影響的人數顯著增加，預計這一趨勢將在一段時間內保持不變。生活方式的顯著改變使世界人口面臨這種疾病和致癌物質的威脅。例如，根據美國癌症協會的數據，到 2022 年，預計新增癌症病例數將達到 190 萬例，死亡人數將達到 609,360 人。公司正專注於擴大臨床液體活體組織切片領域的業務。

例如，2021年12月，Helio Health和Fulgent Genetics宣布推出前者的HelioLiver，這是一種用於早期檢測肝癌的新型液體活體組織切片測試。這種液體活體組織切片結合了血清蛋白標記物和遊離 DNA 甲基化模式。此外，新的研究和開發正在幫助開發新的液體活體組織切片技術。例如，2022 年 7 月，中佛羅裡達大學宣布開發出一種新型液體活體組織切片技術，透過識別生物標記和促進病理監測來促進肺癌和乳癌的早期檢測。

公司對液體活體組織切片的興趣日益濃厚，新產品的核准率不斷提高，進一步加速了市場的成長。此外，近年來，研究顯示液體活體組織切片平台取得了積極的成果。各國政府和各個監管機構也對此領域表現出了興趣，透過推廣多種突破性設備來促進該技術的快速發展。由於各公司對該技術的採用率很高，以及政府資金和舉措的支持，預計該市場在未來幾年將會成長。

液體活體組織切片市場報告亮點

  • 由於 ctDNA 廣泛用作液體活體組織切片癌症檢測中的生物標記物，因此預計將佔據最大的市場佔有率。
  • 由於研究和開發的增加、癌症患者數量的增加、技術的進步以及大公司的策略活動，多基因並行分析（NGS）技術領域預計將出現高速成長。
  • 由於該地區對新技術的需求不斷成長、擁有大量主要企業、擁有多個臨床實驗室以及先進的醫療基礎設施，北美將在 2022 年主導全球市場。
  • 由於目標疾病盛行率上升以及該地區主要企業的存在，預計亞太地區未來將顯著成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素
    • 癌症發生率增加
    • 老年人口增加
    • 技術進步
    • 對非侵入性治療的興趣日益濃厚
  • 市場抑制因素分析
    • 一種重磅處方藥的專利到期
  • 營商環境分析
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
    • COVID-19感染疾病的影響分析

第 4 章 類型業務分析

  • 液體切片市場：類型變異分析
  • 血液樣本
    • 血液樣本市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第5章生物標記業務分析

  • 液體切片市場：生物標記波動分析
  • 循環性腫瘤細胞(CTC)
    • 循環性腫瘤細胞
  • 循環腫瘤 DNA (Catena)
    • 循環核酸市場，2018-2030
  • 胞外體/微囊泡
    • 胞外體/微囊泡市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第6章技術業務分析

  • 液體切片市場：技術變化分析
  • 多基因平行分析（NGS）
    • 多個基因的平行分析
  • 單基因分析（PCR 微陣列）
    • 單基因分析

第7章 應用業務分析

  • 液體切片市場：應用變化分析
  • 癌症
    • 癌症市場，2018-2030
  • 生殖健康
    • 生殖健康市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第 8 章最終用途業務分析

  • 液體活體組織切片市場：最終用途變化分析
  • 醫院/研究所
    • 2018-2030年醫院及研究所市場
  • 專科診所
    • 2018-2030年專科診所市場
  • 學術研究中心
    • 學術研究中心市場，2018-2030
  • 其他
    • 其他液體活體組織切片市場，2018-2030

第9章臨床應用業務分析

  • 液體切片市場：臨床應用波動分析
  • 治療方法選擇
    • 治療方法選擇市場，2018-2030
  • 治療監測
    • 治療監測市場，2018-2030
  • 早期癌症篩檢
    • 早期癌症篩檢市場，2018-2030
  • 監測復發情況
    • 復發監測市場，2018-2030
  • 其他
    • 其他液體活體組織切片市場，2018-2030

第10章產品業務分析

  • 液體切片市場：產品變異分析
  • 裝置
    • 2018-2030年設備市場
  • 耗材套件和試劑
    • 耗材套件與試劑市場，2018-2030
  • 軟體服務
    • 軟體與服務市場，2018-2030

第11章區域業務分析

  • 2023 年和 2030 年液體活體組織切片市場佔有率（按地區）
  • 北美洲
    • 北美液體活體組織切片市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲液體活體組織切片市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太液體活體組織切片市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲液體活體組織切片市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 中東和非洲液體活體組織切片市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第12章競爭形勢

  • 參與企業概況
  • 財務績效
  • 參與企業
    • 市場領導者
    • 2023 年液體切片市場佔有率分析
    • 公司簡介
    • 策略規劃
Product Code: GVR-1-68038-105-4

Liquid Biopsy Market Growth & Trends:

The global Liquid Biopsy Market size was valued at USD 22.88 billion in 2030 and is expected to expand at a compound annual growth rate (CAGR) of 9.7% from 2023 to 2030. The increasing prevalence of cancer and the growing geriatric population are major drivers expected to fuel market growth. Furthermore, the use of technologically advanced devices for early detection of diseases is one of the key factors driving the market. In addition, the increasing preference for noninvasive treatment procedures will offer lucrative opportunities in the forecast period.

In recent years, cases of cancer have been rising tremendously and the trend is projected to remain the same in the foreseeable future. A significant shift in lifestyle has exposed the global population to this disorder and has resulted in oncogenic factors. For instance, as per the American Cancer Society, in 2022, the number of new cancer cases is expected to reach 1.9 million, leading to 609,360 deaths. Companies are focusing on expanding their business operations in the clinical liquid biopsy space.

For instance, in December 2021, Helio Health and Fulgent Genetics announced the launch of the former's HelioLiver, a new liquid biopsy test for early liver cancer detection. This liquid biopsy test combines serum protein markers and cell-free DNA methylation patterns. Additionally, new research studies are aiding the development of novel liquid biopsy techniques. For instance, in July 2022, the University of Central Florida announced the development of a novel liquid biopsy technique that facilitates early detection using biomarker identification for lung and breast cancer, making the monitoring of conditions easier.

The enhanced interest of players in liquid biopsy and the increasing rate of approval of new products are further accelerating market growth. Moreover, in the past several years, studies have shown a positive outcome of liquid biopsy platforms. Governments and various regulatory bodies have also shown interest in the area by promoting multiple breakthrough devices for the rapid development of this technology. With the high adoption of the technology by various companies, along with the support of government funding and initiatives, the market is expected to grow in the coming years.

Liquid Biopsy Market Report Highlights:

  • The ctDNA segment is projected to hold the largest share in the market owing to its wide use as a biomarker in the detection of cancer using liquid biopsy
  • The multi-gene-parallel analysis (NGS) technology segment is expected to grow lucratively due to increasing research and development, increasing cancer cases, advancements in technology, and strategic activities by leading companies
  • North America dominated the global market in 2022, owing to the increasing demand for new technologies, a large pool of key players, the presence of several clinical laboratories, and advanced healthcare infrastructure in the region
  • Asia Pacific is expected to grow considerably in the future, owing to the rising prevalence of target conditions in the region and the presence of key players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Increasing prevalence of cancer
    • 3.4.2. Growing geriatric population
    • 3.4.3. Technological advancements
    • 3.4.4. Increasing preference for noninvasive treatment
  • 3.5. Market Restraint Analysis
    • 3.5.1. Patent expiry of blockbuster drugs prescribed
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Liquid Biopsy Market: Type Movement Analysis
  • 4.2. Blood Sample
    • 4.2.1. Blood Sample Market, 2018 - 2030 (USD Million)
  • 4.3. Others
    • 4.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Biomarker Business Analysis

  • 5.1. Liquid Biopsy Market: Biomarker Movement Analysis
  • 5.2. Circulating Tumor Cells (CTCs)
    • 5.2.1. Circulating Tumor Cells (CTCs) Market, 2018 - 2030 (USD Million)
  • 5.3. Circulating Tumor DNA (catena)
    • 5.3.1. Circulating Nucleic Acids Market, 2018 - 2030 (USD Million)
  • 5.4. Exosomes/Microvesicles
    • 5.4.1. Exosomes/Microvesicles Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Technology Business Analysis

  • 6.1. Liquid Biopsy Market: Technology Movement Analysis
  • 6.2. Multi-gene-parallel Analysis (NGS)
    • 6.2.1. Multi-gene-parallel Analysis (NGS) Market, 2018 - 2030 (USD Million)
  • 6.3. Single Gene Analysis (PCR Microarrays)
    • 6.3.1. Single Gene Analysis (PCR Microarrays) Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Liquid Biopsy Market: Application Movement Analysis
  • 7.2. Cancer
    • 7.2.1. Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.1. Lung Cancer
      • 7.2.1.2. Lung Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.3. Prostate Cancer
      • 7.2.1.4. Prostate Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.5. Breast Cancer
      • 7.2.1.6. Breast Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.7. Colorectal Cancer
      • 7.2.1.8. Colorectal Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.9. Leukemia
      • 7.2.1.10. Leukemia Market, 2018 - 2030 (USD Million)
      • 7.2.1.11. Gastrointestinal Cancer
      • 7.2.1.12. Gastrointestinal Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.13. Others
      • 7.2.1.14. Others Market, 2018 - 2030 (USD Million)
  • 7.3. Reproductive Health
    • 7.3.1. Reproductive Health Market, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-Use Business Analysis

  • 8.1. Liquid Biopsy Market: End-Use Movement Analysis
  • 8.2. Hospitals and Laboratories
    • 8.2.1. Hospitals and Laboratories Market, 2018 - 2030 (USD Million)
  • 8.3. Specialty Clinics
    • 8.3.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
  • 8.4. Academic and Research Centers
    • 8.4.1. Academic and Research Centers Market, 2018 - 2030 (USD Million)
  • 8.5. Others
    • 8.5.1. Others Liquid Biopsy Market, 2018 - 2030 (USD Million)

Chapter 9. Clinical Application Business Analysis

  • 9.1. Liquid Biopsy Market: Clinical Application Movement Analysis
  • 9.2. Therapy Selection
    • 9.2.1. Therapy Selection Market, 2018 - 2030 (USD Million)
  • 9.3. Treatment Monitoring
    • 9.3.1. Treatment Monitoring Market, 2018 - 2030 (USD Million)
  • 9.4. Early Cancer Screening
    • 9.4.1. Early Cancer Screening Market, 2018 - 2030 (USD Million)
  • 9.5. Recurrence Monitoring
    • 9.5.1. Recurrence Monitoring Market, 2018 - 2030 (USD Million)
  • 9.6. Others
    • 9.6.1. Others Liquid Biopsy Market, 2018 - 2030 (USD Million)

Chapter 10. Product Business Analysis

  • 10.1. Liquid Biopsy Market: Product Movement Analysis
  • 10.2. Instruments
    • 10.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 10.3. Consumables Kits and Reagents
    • 10.3.1. Consumables Kits and Reagents Market, 2018 - 2030 (USD Million)
  • 10.4. Software and Services
    • 10.4.1. Software and Services Market, 2018 - 2030 (USD Million)

Chapter 11. Regional Business Analysis

  • 11.1. Liquid Biopsy Market Share By Region, 2023 & 2030
  • 11.2. North America
    • 11.2.1. North America Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.2.2. U.S.
      • 11.2.2.1. Key Country Dynamics
      • 11.2.2.2. Target Disease Prevalence
      • 11.2.2.3. Competitive Scenario
      • 11.2.2.4. Regulatory Framework
      • 11.2.2.5. Reimbursement Scenario
      • 11.2.2.6. U.S. Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.2.3. Canada
      • 11.2.3.1. Key Country Dynamics
      • 11.2.3.2. Target Disease Prevalence
      • 11.2.3.3. Competitive Scenario
      • 11.2.3.4. Regulatory Framework
      • 11.2.3.5. Reimbursement Scenario
      • 11.2.3.6. Canada Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.3. Europe
    • 11.3.1. Europe Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.2. Germany
      • 11.3.2.1. Key Country Dynamics
      • 11.3.2.2. Target Disease Prevalence
      • 11.3.2.3. Competitive Scenario
      • 11.3.2.4. Regulatory Framework
      • 11.3.2.5. Reimbursement Scenario
      • 11.3.2.6. Germany Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.3. UK
      • 11.3.3.1. Key Country Dynamics
      • 11.3.3.2. Target Disease Prevalence
      • 11.3.3.3. Competitive Scenario
      • 11.3.3.4. Regulatory Framework
      • 11.3.3.5. Reimbursement Scenario
      • 11.3.3.6. UK Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.4. France
      • 11.3.4.1. Key Country Dynamics
      • 11.3.4.2. Target Disease Prevalence
      • 11.3.4.3. Competitive Scenario
      • 11.3.4.4. Regulatory Framework
      • 11.3.4.5. Reimbursement Scenario
      • 11.3.4.6. France Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.5. Italy
      • 11.3.5.1. Key Country Dynamics
      • 11.3.5.2. Target Disease Prevalence
      • 11.3.5.3. Competitive Scenario
      • 11.3.5.4. Regulatory Framework
      • 11.3.5.5. Reimbursement Scenario
      • 11.3.5.6. Italy Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.6. Spain
      • 11.3.6.1. Key Country Dynamics
      • 11.3.6.2. Target Disease Prevalence
      • 11.3.6.3. Competitive Scenario
      • 11.3.6.4. Regulatory Framework
      • 11.3.6.5. Reimbursement Scenario
      • 11.3.6.6. Spain Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.7. Denmark
      • 11.3.7.1. Key Country Dynamics
      • 11.3.7.2. Target Disease Prevalence
      • 11.3.7.3. Competitive Scenario
      • 11.3.7.4. Regulatory Framework
      • 11.3.7.5. Reimbursement Scenario
      • 11.3.7.6. Denmark Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.8. Sweden
      • 11.3.8.1. Key Country Dynamics
      • 11.3.8.2. Target Disease Prevalence
      • 11.3.8.3. Competitive Scenario
      • 11.3.8.4. Regulatory Framework
      • 11.3.8.5. Reimbursement Scenario
      • 11.3.8.6. Sweden Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.9. Norway
      • 11.3.9.1. Key Country Dynamics
      • 11.3.9.2. Target Disease Prevalence
      • 11.3.9.3. Competitive Scenario
      • 11.3.9.4. Regulatory Framework
      • 11.3.9.5. Reimbursement Scenario
      • 11.3.9.6. Norway Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.4. Asia Pacific
    • 11.4.1. Asia Pacific Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.2. Japan
      • 11.4.2.1. Key Country Dynamics
      • 11.4.2.2. Target Disease Prevalence
      • 11.4.2.3. Competitive Scenario
      • 11.4.2.4. Regulatory Framework
      • 11.4.2.5. Reimbursement Scenario
      • 11.4.2.6. Japan Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.3. China
      • 11.4.3.1. Key Country Dynamics
      • 11.4.3.2. Target Disease Prevalence
      • 11.4.3.3. Competitive Scenario
      • 11.4.3.4. Regulatory Framework
      • 11.4.3.5. Reimbursement Scenario
      • 11.4.3.6. China Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.4. India
      • 11.4.4.1. Key Country Dynamics
      • 11.4.4.2. Target Disease Prevalence
      • 11.4.4.3. Competitive Scenario
      • 11.4.4.4. Regulatory Framework
      • 11.4.4.5. Reimbursement Scenario
      • 11.4.4.6. India Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.5. South Korea
      • 11.4.5.1. Key Country Dynamics
      • 11.4.5.2. Target Disease Prevalence
      • 11.4.5.3. Competitive Scenario
      • 11.4.5.4. Regulatory Framework
      • 11.4.5.5. Reimbursement Scenario
      • 11.4.5.6. South Korea Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.6. Australia
      • 11.4.6.1. Key Country Dynamics
      • 11.4.6.2. Target Disease Prevalence
      • 11.4.6.3. Competitive Scenario
      • 11.4.6.4. Regulatory Framework
      • 11.4.6.5. Reimbursement Scenario
      • 11.4.6.6. Australia Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.7. Thailand
      • 11.4.7.1. Key Country Dynamics
      • 11.4.7.2. Target Disease Prevalence
      • 11.4.7.3. Competitive Scenario
      • 11.4.7.4. Regulatory Framework
      • 11.4.7.5. Reimbursement Scenario
      • 11.4.7.6. Thailand Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.5. Latin America
    • 11.5.1. Latin America Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.2. Brazil
      • 11.5.2.1. Key Country Dynamics
      • 11.5.2.2. Target Disease Prevalence
      • 11.5.2.3. Competitive Scenario
      • 11.5.2.4. Regulatory Framework
      • 11.5.2.5. Reimbursement Scenario
      • 11.5.2.6. Brazil Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.3. Mexico
      • 11.5.3.1. Key Country Dynamics
      • 11.5.3.2. Target Disease Prevalence
      • 11.5.3.3. Competitive Scenario
      • 11.5.3.4. Regulatory Framework
      • 11.5.3.5. Reimbursement Scenario
      • 11.5.3.6. Mexico Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.4. Argentina
      • 11.5.4.1. Key Country Dynamics
      • 11.5.4.2. Target Disease Prevalence
      • 11.5.4.3. Competitive Scenario
      • 11.5.4.4. Regulatory Framework
      • 11.5.4.5. Reimbursement Scenario
      • 11.5.4.6. Argentina Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.6. MEA
    • 11.6.1. MEA Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.2. South Africa
      • 11.6.2.1. Key Country Dynamics
      • 11.6.2.2. Target Disease Prevalence
      • 11.6.2.3. Competitive Scenario
      • 11.6.2.4. Regulatory Framework
      • 11.6.2.5. Reimbursement Scenario
      • 11.6.2.6. South Africa Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.3. Saudi Arabia
      • 11.6.3.1. Key Country Dynamics
      • 11.6.3.2. Target Disease Prevalence
      • 11.6.3.3. Competitive Scenario
      • 11.6.3.4. Regulatory Framework
      • 11.6.3.5. Reimbursement Scenario
      • 11.6.3.6. Saudi Arabia Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.4. UAE
      • 11.6.4.1. Key Country Dynamics
      • 11.6.4.2. Target Disease Prevalence
      • 11.6.4.3. Competitive Scenario
      • 11.6.4.4. Regulatory Framework
      • 11.6.4.5. Reimbursement Scenario
      • 11.6.4.6. UAE Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.5. Kuwait
      • 11.6.5.1. Key Country Dynamics
      • 11.6.5.2. Target Disease Prevalence
      • 11.6.5.3. Competitive Scenario
      • 11.6.5.4. Regulatory Framework
      • 11.6.5.5. Reimbursement Scenario
      • 11.6.5.6. Kuwait Liquid biopsy market, 2018 - 2030 (USD Million)

Chapter 12. Competitive Landscape

  • 12.1. Participant's overview
  • 12.2. Financial performance
  • 12.3. Participant categorization
    • 12.3.1. Market Leaders
    • 12.3.2. Liquid Biopsy Market Share Analysis, 2023
    • 12.3.3. Company Profiles
      • 12.3.3.1. ANGLE plc
      • 12.3.3.1.1. Company Overview
      • 12.3.3.1.2. Financial Performance
      • 12.3.3.1.3. Product Benchmarking
      • 12.3.3.1.4. Strategic Initiatives
      • 12.3.3.2. Oncimmune Holdings PLC
      • 12.3.3.2.1. Company Overview
      • 12.3.3.2.2. Financial Performance
      • 12.3.3.2.3. Product Benchmarking
      • 12.3.3.2.4. Strategic Initiatives
      • 12.3.3.3. Guardant Health
      • 12.3.3.3.1. Company Overview
      • 12.3.3.3.2. Financial Performance
      • 12.3.3.3.3. Product Benchmarking
      • 12.3.3.3.4. Strategic Initiatives
      • 12.3.3.4. Myriad Genetics, Inc.
      • 12.3.3.4.1. Company Overview
      • 12.3.3.4.2. Financial Performance
      • 12.3.3.4.3. Product Benchmarking
      • 12.3.3.4.4. Strategic Initiatives
      • 12.3.3.5. Biocept, Inc.
      • 12.3.3.5.1. Company Overview
      • 12.3.3.5.2. Financial Performance
      • 12.3.3.5.3. Product Benchmarking
      • 12.3.3.5.4. Strategic Initiatives
      • 12.3.3.6. Lucence Health Inc.
      • 12.3.3.6.1. Company Overview
      • 12.3.3.6.2. Financial Performance
      • 12.3.3.6.3. Product Benchmarking
      • 12.3.3.6.4. Strategic Initiatives
      • 12.3.3.7. Freenome Holdings, Inc.
      • 12.3.3.7.1. Company Overview
      • 12.3.3.7.2. Financial Performance
      • 12.3.3.7.3. Product Benchmarking
      • 12.3.3.7.4. Strategic Initiatives
      • 12.3.3.8. F. Hoffmann-La Roche Ltd.
      • 12.3.3.8.1. Company Overview
      • 12.3.3.8.2. Financial Performance
      • 12.3.3.8.3. Product Benchmarking
      • 12.3.3.8.4. Strategic Initiatives
      • 12.3.3.9. QIAGEN
      • 12.3.3.9.1. Company Overview
      • 12.3.3.9.2. Financial Performance
      • 12.3.3.9.3. Product Benchmarking
      • 12.3.3.9.4. Strategic Initiatives
      • 12.3.3.10. Illumina, Inc.
      • 12.3.3.10.1. Company Overview
      • 12.3.3.10.2. Financial Performance
      • 12.3.3.10.3. Product Benchmarking
      • 12.3.3.10.4. Strategic Initiatives
      • 12.3.3.11. Thermo Fisher Scientific, Inc.
      • 12.3.3.11.1. Company Overview
      • 12.3.3.11.2. Financial Performance
      • 12.3.3.11.3. Product Benchmarking
      • 12.3.3.11.4. Strategic Initiatives
      • 12.3.3.12. Epigenomics AG
      • 12.3.3.12.1. Company Overview
      • 12.3.3.12.2. Financial Performance
      • 12.3.3.12.3. Product Benchmarking
      • 12.3.3.12.4. Strategic Initiatives
    • 12.3.4. Strategy Mapping
      • 12.3.4.1. Expansion
      • 12.3.4.2. Acquisition
      • 12.3.4.3. Collaborations
      • 12.3.4.4. Disease Type/Drug Class Launch
      • 12.3.4.5. Partnerships
      • 12.3.4.6. Others

List of Tables

  • Table 1 List of Tables
  • Table 2 Global Liquid Biopsy Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 Global Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 4 Global Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 5 Global Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 6 Global Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 8 Global Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 9 Global Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 North America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 12 North America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 13 North America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 14 North America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 15 North America Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 16 North America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 17 North America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 U.S. Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 19 U.S. Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 20 U.S. Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 21 U.S. Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 22 U.S. Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 23 U.S. Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 24 U.S. Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Canada Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 26 Canada Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 27 Canada Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 28 Canada Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 Canada Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30 Canada Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 31 Canada Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Europe Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 33 Europe Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 34 Europe Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 35 Europe Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 36 Europe Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 37 Europe Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 38 Europe Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 39 Europe Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 UK Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 41 UK Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 42 UK Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 43 UK Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 UK Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45 UK Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 46 UK Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Germany Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 48 Germany Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 49 Germany Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 50 Germany Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 Germany Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 52 Germany Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 53 Germany Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 France Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 55 France Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 56 France Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 57 France Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 France Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 59 France Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 60 France Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 61 Italy Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 62 Italy Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 63 Italy Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 64 Italy Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 65 Italy Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 66 Italy Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 67 Italy Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 Spain Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 69 Spain Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 70 Spain Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 71 Spain Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 72 Spain Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 73 Spain Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 74 Spain Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 75 Denmark Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 76 Denmark Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 77 Denmark Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 78 Denmark Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Denmark Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 80 Denmark Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 81 Denmark Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 82 Sweden Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 83 Sweden Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 84 Sweden Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 85 Sweden Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 Sweden Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 87 Sweden Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 88 Sweden Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 89 Norway Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 90 Norway Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 91 Norway Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 92 Norway Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 Norway Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 94 Norway Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 95 Norway Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 96 Asia Pacific Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 97 Asia Pacific Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 98 Asia Pacific Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 99 Asia Pacific Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 100 Asia Pacific Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 101 Asia Pacific Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 102 Asia Pacific Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 103 Asia Pacific Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 104 Japan Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 105 Japan Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 106 Japan Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 107 Japan Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 108 Japan Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 109 Japan Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 110 Japan Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 111 China Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 112 China Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 113 China Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 114 China Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 115 China Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 116 China Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 117 China Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 118 India Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 119 India Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 120 India Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 121 India Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 122 India Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 123 India Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 124 India Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 125 Australia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 126 Australia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 127 Australia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 128 Australia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 129 Australia Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 130 Australia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 131 Australia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 132 South Korea Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 133 South Korea Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 134 South Korea Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 135 South Korea Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 136 South Korea Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 137 South Korea Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 138 South Korea Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 139 Thailand Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 140 Thailand Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 141 Thailand Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 142 Thailand Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 143 Thailand Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 144 Thailand Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 145 Thailand Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 146 Latin America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 147 Latin America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 148 Latin America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 149 Latin America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 150 Latin America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 151 Latin America Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 152 Latin America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 153 Latin America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 154 Brazil Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 155 Brazil Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 156 Brazil Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 157 Brazil Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 158 Brazil Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 159 Brazil Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 160 Brazil Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 161 Mexico Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 162 Mexico Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 163 Mexico Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 164 Mexico Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 165 Mexico Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 166 Mexico Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 167 Mexico Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 168 Argentina Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 169 Argentina Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 170 Argentina Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 171 Argentina Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 172 Argentina Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 173 Argentina Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 174 Argentina Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 175 Middle East & Africa Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 176 Middle East & Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 177 Middle East & Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 178 Middle East & Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 179 Middle East & Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 180 Middle East & Africa Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 181 Middle East & Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 182 Middle East & Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 183 South Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 184 South Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 185 South Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 186 South Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 187 South Africa Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 188 South Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 189 South Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 190 Saudi Arabia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 191 Saudi Arabia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 192 Saudi Arabia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 193 Saudi Arabia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 194 Saudi Arabia Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 195 Saudi Arabia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 196 Saudi Arabia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 197 UAE Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 198 UAE Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 199 UAE Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 200 UAE Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 201 UAE Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 202 UAE Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 203 UAE Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 204 Kuwait Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 205 Kuwait Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 206 Kuwait Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 207 Kuwait Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 208 Kuwait Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 209 Kuwait Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 210 Kuwait Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Liquid biopsy market segmentation
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 Market challenge relevance analysis (Current & future impact)
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration vs growth prospect mapping
  • Fig. 15 Liquid biopsy market: Sample Type movement analysis
  • Fig. 16 Blood sample liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 17 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 18 Liquid biopsy market: Biomarker movement analysis
  • Fig. 19 Circulating Tumor Cells (CTCs) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 20 Circulating Nucleic Acids liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 21 Exosomes/Microvesicles liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 22 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 23 Liquid biopsy market: Technology movement analysis
  • Fig. 24 Multi-gene-parallel analysis (NGS) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 25 Single gene analysis (PCR Microarrays) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 26 Liquid biopsy market: Application movement analysis
  • Fig. 27 Cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 28 Lung cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 29 Prostate cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 30 Breast cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 31 Colorectal cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 32 Leukemia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 33 Gastrointestinal cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 34 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 35 Reproductive Health liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 36 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 37 Liquid biopsy market: End-use movement analysis
  • Fig. 38 Hospitals and Laboratories liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 39 Specialty clinics liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 40 Academic and research centers liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 41 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 42 Liquid biopsy market: Clinical application movement analysis
  • Fig. 43 Therapy selection liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 44 Treatment monitoring liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 45 Early cancer screening liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 46 Recurrence monitoring liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 47 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 48 Liquid biopsy market: Product movement analysis
  • Fig. 49 Instruments liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 50 Consumables kits and reagents liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 51 Software and Services liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 Regional outlook, 2018 & 2030
  • Fig. 54 North America liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 55 U.S. liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 56 Canada liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 57 Europe liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 58 UK liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 59 Germany liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 60 Italy liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 61 Spain liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 62 France liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 63 Denmark liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 65 Norway liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 66 Asia Pacific liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 67 Japan liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 68 China liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 69 India liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 70 Australia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 75 Mexico liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 77 MEA liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 80 UAE liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait liquid biopsy market, 2018 - 2030 (USD Million)